Benefit Risk Assessment - Pharma

Relevant Publications

Preoperative susceptibility to developing secondary hyperalgesia is associated with post-thoracotomy pain at 2 months.

Issue Release: 2025

Improved assessments of subsurface projects: Systematic mapping of geosystem services and a review of their economic values.

Issue Release: 2024

Cardio-oncology in advanced prostate cancer.

Issue Release: 2024

Frequency and predictors for early-achieved lupus low disease activity state in systemic lupus erythematosus patients treated with telitacicept or belimumab: A real-life, single-center observational study.

Issue Release: 2024

Assessing the Benefits and Harms of Pharmacotherapy in Older Adults with Frailty: Insights from Pharmacoepidemiologic Studies of Routine Health Care Data.

Issue Release: 2024

Methodological guidelines and publications of benefit-risk assessment for health technology assessment: a scoping review.

Issue Release: 2024

Overutilization of head computed tomography in cases of mild traumatic brain injury: a systematic review and meta-analysis.

Issue Release: 2024

Combining the Nurse Intuition Patient Deterioration Scale with the National Early Warning Score provides more Net Benefit in predicting serious adverse events: A prospective cohort study in medical, surgical, and geriatric wards.

Issue Release: 2024

Chiropractors\' perceptions on the use of spinal radiographs in clinical practice: a qualitative study.

Issue Release: 2024

Association of muscle mass and radiodensity assessed by chest CT with all-cause and cardiovascular mortality in hemodialysis patients.

Issue Release: 2024

The potential role for artificial intelligence in fracture risk prediction.

Issue Release: 2024

Research progress and prospects of benefit-risk assessment methods for umbilical cord mesenchymal stem cell transplantation in the clinical treatment of spinal cord injury.

Issue Release: 2024

Invasive and Non-invasive Assessment of Non-culprit Coronary Lesions in Patients with ST-segment Elevation Myocardial Infarction.

Issue Release: 2024

Prostate cancer risk assessment and avoidance of prostate biopsies using fully automatic deep learning in prostate MRI: comparison to PI-RADS and integration with clinical data in nomograms.

Issue Release: 2024

Treatment options for patients with CADASIL and large-scale cerebral infarction: mechanical thrombectomy and antiplatelet therapy-A case report.

Issue Release: 2024

Sick leaves among healthy pregnant Croatian healthcare workers during the COVID-19 pandemic due to loopholes in the occupational safety system.

Issue Release: 2024

The risk and benefit profiles of US eligible lung cancer screening attendees vs. non-attendees.

Issue Release: 2024

Identifying Populations at Risk for Lung Cancer Mortality from the National Health and Nutrition Examination Survey (2001-2018) Using the 2021 USPSTF Screening Guidelines.

Issue Release: 2024

Sublabial transmaxillary approach to the inferior aspect of the orbit.

Issue Release: 2024

Why is Patient Education Important?

What Are the Therapeutic Approaches to Mitigate Cellular Stress?

What is the Future of Patient Education in Pharma?

Why do Pharma Companies Use CROs?

What are the Challenges in Implementing Collaborative Care Models?

What are the Challenges Faced by Generic Manufacturers?

Who Can Participate in Clinical Trials?

What is Medication Management?

How are New Drugs Discovered?

What is an Abbreviated New Drug Application (ANDA)?

Benefit Risk Assessment - Pharma

Relevant Publications

Partnered Content Networks

Relevant Topics